Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-20

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (ACI Healthcare USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for donepezil hydrochloride (ACI Healthcare USA, Inc.), approving changes to the drug's labeling under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)